Sanofi Pasteur’s Typhim Vi®, granted prequalification by the WHO
23 June 2011 | By Sanofi Pasteur
Sanofi Pasteur, announced that the WHO has granted prequalification to its Typhim Vi® polysaccharide typhoid vaccine...
List view / Grid view
News
GSK statement on agreements with State Attorneys General on former Cidra manufacturing facility
23 June 2011 | By GlaxoSmithKline
GSK has agreed to pay $40.75 million, as part of an agreement...
Roche sets up R&D Institute in France to foster collaborative translational research
23 June 2011 | By Roche
Roche announced the launch of a new R&D Institute in France...
Novo Nordisk invests 1 billion Danish kroner in new factory in Denmark
22 June 2011 | By Novo Nordisk
Novo Nordisk is investing close to 1 billion Danish kroner (134 million euros) in a new factory in Kalundborg, Denmark...
Aesica appoints new European Manager
22 June 2011 | By Velvet Communications Limited
Aesica Pharmaceuticals has announced the appointment of Nicolas Micheaud as Regional Sales Manager – Western Europe...
Sanofi establishes a global agreement with Medco and UBC
22 June 2011 | By Sanofi
To better leverage the real-world evidence generated during product development and throughout the product lifecycle...
AstraZeneca to sell AstraTech to DENTSPLY International
22 June 2011 | By AstraZeneca
AstraZeneca has agreed to sell its Astra Tech business to DENTSPLY for approximately $1.8 billion in cash...
Novozymes Biopharma to present on creating market opportunities through drug half-life extension
22 June 2011 | By The Scott Partnership
Novozymes Biopharma, will host a panel session at the BIO Business Forum...
BYDUREON™ receivies marketing authorisation in Europe
21 June 2011 | By Eli Lilly and Company
Eli Lilly and Company, together with Amylin Pharmaceuticals, Inc. and Alkermes, Inc., announced that the European Commission has granted marketing authorization to BYDUREON™...
Pfizer selects Exco InTouch’s novel eDiary technologies to initiate first ever Patient-Centered clinical trial
21 June 2011 | By The Scott Partnership
Exco InTouch, announced that its novel eDiary technologies have been selected by Pfizer...
ERT appoints Robert Kleiman MD to Chief Medical Officer
21 June 2011 | By ERT
ERT, announced that Robert Kleiman, has been appointed to the role of Chief Medical Officer...
FDA panel endorses efficacy but not safety of Novartis drug ACZ885 for gouty arthritis
21 June 2011 | By Novartis
FDA panel voted in favor of the overall efficacy but not the overall safety of ACZ885...
Pfizer’s Lyrica top-line results positive in global Phase 3 Study
21 June 2011 | By Pfizer
Pfizer Inc. announced that top-line results for Lyrica Study A0081107, demonstrated that the study met its primary endpoint...
Thermo Fisher Scientific introduces expanded chromatography portfolio
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it will show its expanded portfolio of market-leading chromatography solutions within the Thermo Scientific and Dionex booths at HPLC 2011, a first since Thermo Fisher acquired Dionex.
Abbott receives FDA approval for a new six-month formulation of Lupron Depot®
20 June 2011 | By Abbott
"Lupron Depot is an important treatment option for many patients..."
